Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS ( Gold Medalist), FCPS (Gastroenterology), MRCP-1 [UK]
Internal Medicine Specialist
MBBS ( Gold Medalist), FCPS (Gastroenterology), MRCP-1 [UK]
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Nephrologist
M.B.B.S (K.E), MRCP (UK), FCPS (Nephrology), ESCE (Nephrology) (UK), CHPE (LGU), Certified Nephrology
Nephrologist
M.B.B.S (K.E), MRCP (UK), FCPS (Nephrology), ESCE (Nephrology) (UK), CHPE (LGU), Certified Nephrology
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Cardiologist
MBBS, MD(USA), FCPS (Cardiology)
Consultant Physician
M.B.B.S., F.C.P.S., M.R.C.P, F.R.C.P.
Internal Medicine Specialist
MD, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Diabetologist
MBBS, FCPS , MRCP, MRCP (UK), SCE Endocrinology and Diabetes (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures